Pharmacokinetic and pharmacodynamic consequences of inhibition of terazosin metabolism via CYP3A1 and/or 3A2 by DA-8159, an erectogenic, in rats. [electronic resource]
Producer: 20070727Description: 24-34 p. digitalISSN:- 0007-1188
- Animals
- Aryl Hydrocarbon Hydroxylases -- physiology
- Cytochrome P-450 CYP3A
- Dexamethasone -- pharmacology
- Drug Interactions
- Male
- Membrane Proteins -- physiology
- Microsomes, Liver -- metabolism
- Prazosin -- administration & dosage
- Pyrimidines -- pharmacokinetics
- Rats
- Rats, Sprague-Dawley
- Sulfonamides
- Troleandomycin -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.